Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

23.12.24	Bristol Myers: Sotyktu Phase 3 Trials In Psoriatic Arthritis Meet Primary Goals (RTTNews)
02.12.24	Biotech Stocks Facing FDA Decision In December 2024 (RTTNews)
31.10.24	Bristol Myers Squibb Lifts FY24 Earnings View Above Market; Stock Up In Pre-market - Update (RTTNews)
31.10.24	Bristol-Myers Squibb Co. Q3 Profit Decreases, But Beats Estimates (RTTNews)
30.09.24	Prime Medicine Inks Strategic Research Collaboration And License Agreement With Bristol Myers Squibb (RTTNews)
30.09.24	Biotech Stocks Facing FDA Decision In October 2024 (RTTNews)
27.09.24	Bristol Myers Squibb's COBENFY Gains FDA Approval For Adult Schizophrenia Treatment (RTTNews)
25.09.24	2seventy, Bristol Myers Discontinue Enrollment In Phase 3 KarMMa-9 Study - Quick Facts (RTTNews)
05.09.24	Merck's Winrevair Approved For Pulmonary Arterial Hypertension In Canada (RTTNews)
02.09.24	Biotech Stocks Facing FDA Decision In September 2024 (RTTNews)
01.09.24	Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies (RTTNews)
21.08.24	Bristol Myers : FDA Accepts SBLA For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (RTTNews)
19.08.24	EMA Validates Bristol Myers Squibb's Application For CAR T Cell Therapy Breyanzi (RTTNews)
13.08.24	Evotec Secures $75 Mln In Milestone Payments From Bristol Myers Amid Pipeline Advancements (RTTNews)
11.08.24	Weekly Review: ANTX Downsizes, ALDX Aces Dry Eye Disease Trial, FDA Oks 1st Epinephrine Nasal Spray (RTTNews)
26.07.24	Bristol Myers Squibb Raises 2024 Non-GAAP Guidance (RTTNews)
26.07.24	Bristol-Myers Squibb Co. Q2 Profit Decreases, But Beats Estimates (RTTNews)
19.07.24	Bristol Myers Squibb Receives EMA Validation For Opdivo Plus Yervoy For Treatment Of HCC (RTTNews)
05.06.24	I-Mab Inks Partnership With Bristol Myers Squibb To Evaluate Givastomig In Combination Study (RTTNews)
03.06.24	Bristol Myers' 3 Breyanzi Trials Show Consistent Benefit Across B-Cell Malignancies (RTTNews)
06.05.24	Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation (RTTNews)
30.04.24	Biotech Stocks Facing FDA Decision In May 2024 (RTTNews)
29.04.24	Repertoire Immune Medicines In Strategic Partnership With Bristol Myers Squibb (RTTNews)
26.04.24	Bristol Myers: CHMP Recommends Approval Of Opdivo In Combination With Cisplatin And Gemcitabine (RTTNews)
25.04.24	Bristol Myers Squibb Posts Loss In Q1; Updates 2024 Non-GAAP EPS Guidance (RTTNews)
25.04.24	Bristol-Myers Squibb Co. Q1 Earnings Summary (RTTNews)
05.04.24	Bristol Myers, 2seventy Bio Get FDA Nod For Abecma For Relapsed Multiple Myeloma Patients (RTTNews)
01.04.24	Zai Lab: Bristol Myers' KRYSTAL-12 Confirmatory Trial With Adagrasib Meets Meets Primary Endpoint (RTTNews)
19.03.24	Perspective Therapeutics Inks Clinical Trial Collaboration Agreement With Bristol Myers (RTTNews)
18.03.24	Bristol Myers Squibb Completes Acquisition Of Karuna Therapeutics - Quick Facts (RTTNews)
28.02.24	Biotech Stocks Facing FDA Decision In March 2024 (RTTNews)
23.02.24	Bristol Myers Squibb: Approx. 86% Of RayzeBio Common Stock Validly Tendered As Of Expiration Time (RTTNews)
14.02.24	Bristol-Myers' Augtyro Receives Priority Review Status From FDA (RTTNews)
12.02.24	Bristol Myers Squibb, RayzeBio Report Expiration Of HSR Act Waiting Period (RTTNews)
02.02.24	Bristol-Myers Squibb Guides FY24 Adj. EPS Above Estimates As Q4 Results Top Estimates - Update (RTTNews)
02.02.24	Bristol-Myers Squibb Co. Q4 Profit Decreases, but beats estimates (RTTNews)
30.01.24	Bristol-Myers Says Regulatory Applications For Breyanzi Accepted By FDA, Japan's MHLW (RTTNews)
26.01.24	Bristol-Myers's Abecma Receives CHMP Recommendation For Market Authorization (RTTNews)
23.01.24	Bristol Myers Squibb Completes Acquisition Of Mirati For Upto $5.8 Bln (RTTNews)
26.12.23	Bristol Myers Squibb To Acquire RayzeBio For $62.50/share In All-cash Deal (RTTNews)
22.12.23	Bristol Myers Squibb To Acquire Karuna Therapeutics For $330/share Cash (RTTNews)
14.12.23	Terray, Bristol Myers Squibb Join To Identify Small Molecule Therapeutics Using TNova Platform (RTTNews)
14.12.23	Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb (PR Newswire)
07.12.23	Bristol Myers Squibb To Repurchase Additional $3 Bln Of Shares (RTTNews)
05.12.23	Bristol Myers: FDA Accepts SBLA For Opdivo Combination For Priority Review (RTTNews)
28.11.23	Avidity Biosciences Inks Global Licensing And Research Collaboration Deal With Bristol Myers Squibb (RTTNews)
28.11.23	Avidity Biosciences Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb for up to Five Targets Utilizing Avidity's Proprietary AOC™ Platform Technology (PR Newswire)
20.11.23	Bristol Myers Squibb, 2seventy Bio Issue Update On FDA Review For Abecma (RTTNews)
01.11.23	Bristol Myers Squibb Elects Christopher Boerner To Serve As Chair Of Board (RTTNews)
30.10.23	Karyopharm Enters Clinical Trial Collaboration, Supply Agreement With Bristol-Myers Squibb (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

17:58		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge
17:58		Börse Frankfurt: DAX zum Handelsende auf grünem Terrain
17:58		Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
17:58		SLI-Handel aktuell: Zum Handelsende Gewinne im SLI
17:58		Freitagshandel in Frankfurt: LUS-DAX zeigt sich letztendlich fester
16:01		Verluste in New York: Dow Jones präsentiert sich zum Start leichter
15:58		Handel in Frankfurt: LUS-DAX am Freitagnachmittag mit grünem Vorzeichen

17:58

Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

17:58

Börse Frankfurt: DAX zum Handelsende auf grünem Terrain

17:58

Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

17:58

SLI-Handel aktuell: Zum Handelsende Gewinne im SLI

17:58

Freitagshandel in Frankfurt: LUS-DAX zeigt sich letztendlich fester

16:01

Verluste in New York: Dow Jones präsentiert sich zum Start leichter

15:58

Handel in Frankfurt: LUS-DAX am Freitagnachmittag mit grünem Vorzeichen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Bristol-Myers Squibb Co.

Aktien Top/Flop

Bristol-Myers Squibb Peer Group Nachrichten

Meistgelesene Nachrichten